Secondary vasculitis – omitted manifestation of many diseases

Česká verzia

Authors: Radim Bečvář
Authors place of work: Revmatologický ústav a Revmatologická klinika 1. LF UK, Praha
Published in the journal: Čes.-slov. Patol., 56, 2020, No. 2, p. 83-88
Category: Reviews Article

Summary

Secondary vasculitides usually accompany various common and rare conditions, Their clinical picture is very diverse, they can be loclaized or genaralized. Most frequently, we find parainfectious, drug-related and paraneoplastic vasculitides, less commonly in connective tissue diseases, after radiotherapy or transplantation. Vasculitides may be associated to infection of any origin. Drug-related vasculitides are mainly confined to the skin with picture of leukocytoclastic angiitis but visceral organs may be involved too. Paraneoplastic vasculitides usually accompany solid tumours and lymphoproliferative processes. When related to connective tissue diseases we can observe vasculitis in rheumatoid arthritis, systemic lupus erythematosus, Sjoegren syndrome, systemic sclerosis and other conditions. The diagnosis of vasculitis is usually based on pathological findings from biopsy. Management lies in treatment of underlying disease and if it is ineffective combined immunosuppression should be introduced.

Keywords:

vasculitis – Drugs – infection – neoplasms – connective tissue diseases – irradiation

Zdroje

1. Bečvář R, Rovenský J. Sekundárné vaskulitídy pri systémových ochoreniach spojivového tkaniva a poliekové vaskulitídy. Vaskulárna medicína 2010; 2: 120-126.

2. Bečvář R, Tesař V, Rychlík I. Vaskulitidy v klinické praxi - diagnostika a terapie. (1. vyd) Praha: Medprint; 1994, 70-96.

3. Teng GG, Chaimnuay S, Chatham WW. Miscellaneous forms of vasculitis. In: Ball GV, Louis Bridges S Jr, eds. Vasculitis (2nd ed). Oxford: Oxford University Press; 2008: 545-550.

4. Doyle MK, Cuellar ML. Drug-induced vasculitis. Expert Opin Drug Saf 2003; 2: 401-409.

5. Dubost JJ, Souteyrand E, Sauvezie B. Drug-induced vasculitides. Baillieres Clin Rheumatol 1991; 5: 119-138.

6. Ramos-Casals M, Brito-Zerón P, Cuadrado MJ, Khamashta MA. Vasculitis induced by tumor necrosis factor-targeted therapies. Curr Rheumatol Rep 2008; 10: 442-448.

7. Gao Y, Zhao MH. Drug-induced anti-neutrophil cytoplasmic antibody-associated vasculitis. Nephrology (Carlton) 2009; 14: 33-41.

8. Wiik A. Drug-induced vasculitis. Curr Opin Rheumatol 2008; 20: 35-39.

9. Breedveld FC. Vasculitis associated with connective tissue disease. Bailliers Clin Rheumatol 1997; 11: 315-334.

10. Voskuyl AE, Zwindrmann AH, Westedt ML et al. Factors associated with the development of vasculitis in rheumatoid arthritis: results of case-control study. Ann Rheum Dis 1996; 55: 190-192.

11. Genta MS, Genta RM, Gabay C. Systemic rheumatoid vasculitis. Semin Arthritis Rheum. 2006; 36: 88-98.

12. Ramos-Casals M, Nardi N, Lagrutta M et al. Vasculitis in systemic lupus erythematosus: prevalence and clinical characteristics in 670 patients. Medicine (Baltimore) 2006; 85: 95-104.

13. Belmont HM, Abramson SB, Lie JT. Pathology and pathogenesis of vascular injury in systemic lupus erythematosus. Arthritis Rheum 1996; 39 9-22.

14. Drenkard C, Villa AR, Reyes E, Abello M, Alarcon-Segovia D. Vasculitis in systemic lupus erythematosus. Lupus 1997; 6: 235-242.

15. Calamia KT, Balabanova M. Vasculitis in systemic lupus erythematosus. Clin Dermatol 2004; 22: 148-156

16. Ramos-Casals M, Anaya JM, Garcia-Carrasco M et al. Cutaneous vasculitis in primary Sjögren syndrome: classification and clinical significance of 52 patients. Medicine (Baltimore) 2004; 83: 96-106.

17. Fox RI. Sjogren’s syndrome. Lancet 2005; 366: 321-331.

18. Carsons S. A review and update of Sjogren’s syndrome: manifestation, diagnosis, and treatment. Amer J Managed Care 2001; 7(Suppl): S433-S443.

19. Kahaleh MB. Raynaud‘s phenomenon and the vascular disease in scleroderma. Curr Opin Rheumatol 1995; 76: 529-534.

20. Herrick AL, Oogarah PK, Freemont AJ et al. Vasculitis in patients with systemic sclerosis and severe digital ischemia requiring amputation. Ann Rheum Dis 1994; 53: 323-326.

21. Sy A, Khalidi N, Dehghan N et al. Vasculitis in patients with inflammatory bowel diseases: A study of 32 patients and systematic review of the literature. Semin Arthritis Rheum 2016; 45: 475-482.

22. Fam AG. Paraneoplastic rheumatic syndromes. Bailliére´s Clinical Rheumatology 2000; 14: 515–533.

23. Mertz LE., Conn DL. Vasculitis associated with malignancy. Curr Opin Rheum 1992; 4: 39–46.

24. Ballester M, Obrador D, Carrió I et al. Reversal of rejection-induced coronary vasculitis detected early after heart transplantation with increased immunosuppression. Heart Transplant 1989; 8: 413-417.